Photo by nci from unsplash
acute respiratory insufficiency. At one month, no EL was detected. The average follow-up was 10 months (one lost to follow-up at one month). 100% of the AAAs were excluded. Mortality… Click to show full abstract
acute respiratory insufficiency. At one month, no EL was detected. The average follow-up was 10 months (one lost to follow-up at one month). 100% of the AAAs were excluded. Mortality was 4% (one CVA). Two patients (8%) presented a thrombotic complication: one popliteal thrombosis, two successive limb thromboses requiring the explantation of the stentgraft (14 months). Diameters were stable: D max1⁄454±8mm (-2.4%; NS). No EL was observed. One noted no complication related to the endobags. Conclusion: The endovascular treatment of the noncomplicated AAA by EVAS has encouraging short and mid-term results in selected patients. Our study suggests that the EVAS concept of the Nellix stentgraft is effective to avoid EL2. A longer-term follow-up is necessary.
Journal Title: Annals of vascular surgery
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!